The Role of Immune and Inflammatory-Related Indicators in Cognitive Dysfunction and Disease Severity in Patients with Parkinson's Disease.

Xudong Zhao,Lei Li,Xiuping Ma,Yang Li,Beibei Gao,Weifeng Luo
DOI: https://doi.org/10.1007/s00702-023-02704-8
IF: 3.85
2023-01-01
Journal of Neural Transmission
Abstract:We aimed to explore the role of immune and inflammatory indicators in cognitive dysfunction and disease severity in patients with Parkinson's disease (PD). A total of 123 patients with Parkinson's disease were enrolled in the PD group and 49 healthy volunteers in the control group. The patients with PD were further divided into 2 subgroups by evaluating cognitive function using the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE): the normal cognitive function (PD-NCI) group and the mild cognitive impairment (PD-MCI) group. Moreover, the PD patients were also divided into 2 subgroups using the defined scale of the Hoehn and Yahr (H-Y) stage: the early-stage group and the middle- and late-stage group. Immune and inflammatory indicators, including serum Aβ1−42, Tau, CD4+, CD8+, CD3+, B lymphocytes cell, NK cell, Th17 cell, Treg cell, IL-6, IL-17, and TNF-α levels, were evaluated and analyzed to explore the potential correlation with the cognitive dysfunction and disease severity of PD. Among the 123 PD patients, 60 (48.8
What problem does this paper attempt to address?